Immunic announces participation in July investor conferences

Immunic Inc (NASDAQ:IMUX, FRA:10VA) said it will participate in three investor conferences in July.

Company executives, including CEO Erik Lundgren, President and COO Jason Tardio, and Chief Medical Officer Michael A. Panzara, will attend the Leerink Partners Therapeutics Forum on July 14-15 in Boston, the B. Riley Securities Mind, Muscle & Vision Summit on July 16, where they will take part in a fireside chat, and the LifeSci Capital SF Biotech Forum on July 23 in San Francisco.